- Home
- MRNA vs GIB Comparison
MRNA vs GIB Comparison
Compare MRNA & GIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | GIB |
|---|---|---|
| Founded | 2010 | 1976 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 16.0B |
| IPO Year | 2018 | 1999 |
Fundamental Metrics
Financial Performance| Metric | MRNA | GIB |
|---|---|---|
| Price | $49.11 | $74.04 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 12 | 3 |
| Target Price | $33.00 | ★ $117.00 |
| AVG Volume (30 Days) | ★ 7.1M | 350.3K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.64% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | N/A |
| Revenue This Year | $8.59 | $8.33 |
| Revenue Next Year | $16.72 | $2.96 |
| P/E Ratio | ★ N/A | $13.59 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $69.96 |
| 52 Week High | $59.55 | $110.07 |
Technical Indicators
Market Signals| Indicator | MRNA | GIB |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 50.83 |
| Support Level | $48.09 | $69.96 |
| Resistance Level | $54.94 | $75.34 |
| Average True Range (ATR) | 2.63 | 1.79 |
| MACD | -0.77 | 0.45 |
| Stochastic Oscillator | 17.40 | 86.97 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.